ELAN - CIK 0001739104
The table below shows Elanco Animal Health Inc's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $560.00M | $541.00M | $271.00M | $452.00M | $483.00M | -$41.00M |
| Capital expenditure | $276.00M | $147.00M | $140.00M | $171.00M | $159.00M | $135.00M |
| Investing cash flow | -$279.00M | $1.16B | -$169.00M | -$179.00M | -$530.00M | -$4.78B |
| Dividends paid | - | - | - | - | - |
Elanco Animal Health Inc reported operating cash flow of $560.00M for fiscal year 2025. That is up 3.5% from $541.00M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $155.90M (FY 2016) to $560.00M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$275.00M | -$1.49B | -$83.00M | -$549.00M | $210.00M | $4.95B |